For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the emergence of this treatment and the formulated version represents a true advancement . These innovative therapies stabilize the transthyretin protein, halting its damaging build-up and lessening the severity of the condition . Individuals are no